ロード中...
IMMU-04. OVERCOMING IMMUNE EVASION IN GLIOBLASTOMA
The negative phase 3 trial of anti-PD-1 in human glioblastoma (GBM) contradicts preclinical data showing eradication of GL261 mouse brain tumors by checkpoint inhibitors (CPI). To understand whether the tumor microenvironment contributed to this discrepancy, we immunoprofiled 19 human GBM tumors by...
保存先:
| 出版年: | Neuro Oncol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6217332/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.507 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|